Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309938140> ?p ?o ?g. }
- W4309938140 endingPage "311" @default.
- W4309938140 startingPage "298" @default.
- W4309938140 abstract "There is an urgent need to identify biomarkers of early response that can accurately predict the benefit of immune checkpoint inhibitors (ICI). Patients receiving durvalumab/tremelimumab had tumor samples sequenced before treatment (baseline) to identify variants for the design of a personalized circulating tumor (ctDNA) assay. ctDNA was assessed at baseline and at 4 and/or 8 weeks into treatment. Correlations between ctDNA changes to radiographic response and overall survival (OS) were made to assess potential clinical benefit. 35/40 patients (87.5%) had personalized ctDNA assays designed, and 29/35 (82.9%) had plasma available for baseline analysis, representing 16 unique solid tumor histologies. As early as 4 weeks after treatment, decline in ctDNA from baseline predicted improved OS (P = 0.0144; HR = 9.98) and ctDNA changes on treatment-supported and refined radiographic response calls. ctDNA clearance at any time through week 8 identified complete responders by a median lead time of 11.5 months ahead of radiographic imaging. ctDNA response monitoring is emerging as a dynamic, personalized biomarker method that may predict survival outcomes in patients with diverse solid tumor histologies, complementing and sometimes preceding standard-of-care imaging assessments." @default.
- W4309938140 created "2022-11-30" @default.
- W4309938140 creator A5002987297 @default.
- W4309938140 creator A5022347965 @default.
- W4309938140 creator A5025938903 @default.
- W4309938140 creator A5032009066 @default.
- W4309938140 creator A5041929329 @default.
- W4309938140 creator A5045665778 @default.
- W4309938140 creator A5051679566 @default.
- W4309938140 creator A5052504293 @default.
- W4309938140 creator A5053767152 @default.
- W4309938140 creator A5056579841 @default.
- W4309938140 creator A5057483557 @default.
- W4309938140 creator A5063297268 @default.
- W4309938140 creator A5064275932 @default.
- W4309938140 creator A5081534856 @default.
- W4309938140 creator A5082768519 @default.
- W4309938140 date "2022-12-13" @default.
- W4309938140 modified "2023-09-24" @default.
- W4309938140 title "Early circulating tumor <scp>DNA</scp> dynamics as a pan‐tumor biomarker for long‐term clinical outcome in patients treated with durvalumab and tremelimumab" @default.
- W4309938140 cites W1996865879 @default.
- W4309938140 cites W2033532043 @default.
- W4309938140 cites W2100158834 @default.
- W4309938140 cites W2122377763 @default.
- W4309938140 cites W2160981405 @default.
- W4309938140 cites W2559382297 @default.
- W4309938140 cites W2560367415 @default.
- W4309938140 cites W2606495925 @default.
- W4309938140 cites W2607977201 @default.
- W4309938140 cites W2608738563 @default.
- W4309938140 cites W2754606968 @default.
- W4309938140 cites W2789072552 @default.
- W4309938140 cites W2899311685 @default.
- W4309938140 cites W2900082702 @default.
- W4309938140 cites W2914335731 @default.
- W4309938140 cites W2944044607 @default.
- W4309938140 cites W2969333588 @default.
- W4309938140 cites W2977801430 @default.
- W4309938140 cites W2983284890 @default.
- W4309938140 cites W3006553021 @default.
- W4309938140 cites W3033718997 @default.
- W4309938140 cites W3047097799 @default.
- W4309938140 cites W3049083268 @default.
- W4309938140 cites W3083986479 @default.
- W4309938140 cites W3136175145 @default.
- W4309938140 cites W3139130539 @default.
- W4309938140 cites W3187047625 @default.
- W4309938140 cites W3200725972 @default.
- W4309938140 cites W3203043035 @default.
- W4309938140 cites W3209985482 @default.
- W4309938140 cites W3212198841 @default.
- W4309938140 cites W4205565447 @default.
- W4309938140 cites W4206343048 @default.
- W4309938140 cites W4213370500 @default.
- W4309938140 cites W4220859775 @default.
- W4309938140 cites W4283803057 @default.
- W4309938140 cites W4297982435 @default.
- W4309938140 cites W8539555 @default.
- W4309938140 doi "https://doi.org/10.1002/1878-0261.13349" @default.
- W4309938140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36426653" @default.
- W4309938140 hasPublicationYear "2022" @default.
- W4309938140 type Work @default.
- W4309938140 citedByCount "3" @default.
- W4309938140 countsByYear W43099381402023 @default.
- W4309938140 crossrefType "journal-article" @default.
- W4309938140 hasAuthorship W4309938140A5002987297 @default.
- W4309938140 hasAuthorship W4309938140A5022347965 @default.
- W4309938140 hasAuthorship W4309938140A5025938903 @default.
- W4309938140 hasAuthorship W4309938140A5032009066 @default.
- W4309938140 hasAuthorship W4309938140A5041929329 @default.
- W4309938140 hasAuthorship W4309938140A5045665778 @default.
- W4309938140 hasAuthorship W4309938140A5051679566 @default.
- W4309938140 hasAuthorship W4309938140A5052504293 @default.
- W4309938140 hasAuthorship W4309938140A5053767152 @default.
- W4309938140 hasAuthorship W4309938140A5056579841 @default.
- W4309938140 hasAuthorship W4309938140A5057483557 @default.
- W4309938140 hasAuthorship W4309938140A5063297268 @default.
- W4309938140 hasAuthorship W4309938140A5064275932 @default.
- W4309938140 hasAuthorship W4309938140A5081534856 @default.
- W4309938140 hasAuthorship W4309938140A5082768519 @default.
- W4309938140 hasBestOaLocation W43099381401 @default.
- W4309938140 hasConcept C121608353 @default.
- W4309938140 hasConcept C126322002 @default.
- W4309938140 hasConcept C143998085 @default.
- W4309938140 hasConcept C2777701055 @default.
- W4309938140 hasConcept C2777742743 @default.
- W4309938140 hasConcept C2778650287 @default.
- W4309938140 hasConcept C2779984678 @default.
- W4309938140 hasConcept C2780030458 @default.
- W4309938140 hasConcept C2781197716 @default.
- W4309938140 hasConcept C2781335228 @default.
- W4309938140 hasConcept C2781433595 @default.
- W4309938140 hasConcept C31760486 @default.
- W4309938140 hasConcept C535046627 @default.
- W4309938140 hasConcept C55493867 @default.
- W4309938140 hasConcept C71924100 @default.
- W4309938140 hasConcept C86803240 @default.
- W4309938140 hasConceptScore W4309938140C121608353 @default.